Trade GLUE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Monte Rosa Therapeutics, Inc. (GLUE) is trading at US$12.13, down 3.73% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.22B. Over the past 52 weeks, GLUE has traded between US$6.23 and US$25.77. On Syfe you can trade GLUE with $0 commission and add it to your watchlist.
| Previous close | US$12.60 |
|---|---|
| Market cap | US$1.22B |
| 52-week range | US$6.23 – US$25.77 |
| Volume | 1.6M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
Year: 2021
-- Earnings Flash (GLUE) Monte Rosa Therapeutics, Inc. Reports Q2 Collaboration Revenue $9.0M, vs. FactSet Est of $12.9M
Aug 6, 11:15 AM · MT Newswires
Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial
Jul 31, 6:24 PM · MT Newswires
Monte Rosa Therapeutics, Inc. (GLUE) stock is trading at US$12.13, -3.73% from the previous close of US$12.60.
The market cap for Monte Rosa Therapeutics, Inc. (GLUE) stock is approximately US$1.22B.
The 52-week high for Monte Rosa Therapeutics, Inc. (GLUE) stock is US$25.77.
The 52-week low for Monte Rosa Therapeutics, Inc. (GLUE) stock is US$6.23.
Monte Rosa Therapeutics, Inc. (GLUE) does not currently pay a dividend.
Stay on top of GLUE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
